[In the Media] The 11th NIKKEI FT Communicable Diseases Conference: On Building a Crisis-Resilient Society (The Nikkei, December 27, 2024)
date : 1/15/2025
Tags: AMR, Vaccinations
A comment by Health and Global Policy Institute (HGPI) Chair Mr. Ryoji Noritake at the “10th Special Session Promoting Sustainable Research and Development for Combating Antimicrobial Resistance: Challenges in Incentives and the Importance of Global Collaboration” held during the 11th NIKKEI FT Communicable Diseases Conference (hosted by Nikkei Inc. and co-hosted by the Financial Times) was featured in the December 27 print edition of the Nikkei.
This article addresses the increasing need to expand incentive systems that will underpin the way forward in tackling human resource and clinical research system challenges currently faced in advancing research and development of new antimicrobials.
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)



